Mistletoe

Titlesort descending Average Rating
66 year man. Cholangiocarcinoma 80.00%
71 year old woman. Breast cancer with bone metastasis 90.00%
Adjuvant simultaneous mistletoe chemotherapy in breast cancer--influence on immunological parameters, quality of life and tolera 50.00%
Adjuvante simultane Mistel-/Chemotherapie bei Mammakarzinom – Einfluss auf Immunparameter, Lebensqualität und Verträglichkeit 50.00%
Complementary and alternative medicines taken by cancer patients 80.00%
Immunologic effector mechanisms of a standardized mistletoe extract on the function of human monocytes and lymphocytes in vitro, 50.00%
Impact of complementary treatment of breast cancer patients with standardized mistletoe extract during aftercare: a controlled m 80.00%
Individual Patient Data Meta-analysis of Survival and Psychosomatic Self-regulation from Published Prospective Controlled Cohort 80.00%
Mistletoe as a treatment for cancer. Has no proved benefit, and can cause harm 20.00%
Mistletoe in conventional oncological practice: exemplary cases. 40.00%
Mistletoe Therapy in Cancer 83.33%
Mistletoe therapy in oncology 90.00%
Prospective controlled cohort studies on long-term therapy of breast cancer patients with a mistletoe preparation (Iscador) 80.00%
Prospective controlled cohort studies on long-term therapy of cervical cancer patients with a mistletoe preparation (Iscador). 90.00%
Randomized and non-randomized prospective controlled cohort studies in matched pair design for the long-term therapy of corpus u 50.00%
Reducing malignant ascites accumulation by repeated intraperitoneal administrations of a Viscum album extract. 95.00%